US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Talphera Inc.

0.4851

-0.0049-1.00%

Volume:21.58K

Turnover:10.47K

Market Cap:9.95M

PE:-1.09

High:0.4900

Open:0.4900

Low:0.4751

Close:0.4900

Loading ...

Overview Company News Filings

Talphera Inc. Receives Nasdaq Extension to Regain Compliance with $1.00 Bid Price Rule

Talphera Inc reports results for the quarter ended March 31 - Earnings Summary

Talphera Inc. Reports Q1 2025 Net Loss of $2.6 Million, EPS Improves to $0.10 from $0.16 in 2024

Talphera Q1 EPS $(0.10) Beats $(0.14) Estimate, Sales $27.00K

Talphera Inc expected to post a loss of 15 cents a share - Earnings Preview

Talphera Inc expected to post a loss of 15 cents a share - Earnings Preview

Talphera Price Target Maintained With a $6.00/Share by HC Wainwright & Co.

BRIEF-Talphera Expected To Provide Capital Through Target Completion Of Nephro Study In Q4 Of 2025

Talphera Inc reports results for the quarter ended December 31 - Earnings Summary

Talphera: Expected to Provide Capital Through Target Completion of Nephro Study in Q4 of 2025

THOMSON REUTERS

Talphera Q4 2024 GAAP EPS $(0.07) Beats $(0.16) Estimate

Talphera to Reduce Size of Renal Replacement Therapy Study, Enters Private Placement; Shares Fall

MT Newswires Live

Talphera Inc - Talphera Believes Nephro Crrt Study Should Be Completed by End of 2025

THOMSON REUTERS

Talphera Announces Agreement With the FDA to Reduce the Nephro Crrt Study Size to 70 Patients From 166 and a Private Placement Financing Priced at-the Market of up to $14.8 Million

THOMSON REUTERS

Talphera Inc expected to post a loss of 16 cents a share - Earnings Preview

Talphera Inc expected to post a loss of 16 cents a share - Earnings Preview

Talphera reaches agreement with FDA in Nephro CRRT study

BRIEF-Talphera Announces Agreement With The FDA For Prior Approval Supplement Review To Reduce The Number Of Patients In The the NEPHRO CRRT Study

Talphera Inc: FDA Agreed to Two Additional Protocol Changes Expected to Accelerate Enrollment in Nephro Crrt Study

THOMSON REUTERS

Talphera Announces Agreement With the FDA for Prior Approval Supplement Review to Reduce the Number of Patients in the Nephro Crrt Study

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/TLPH/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TLPH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TLPH\",,,,,undefined,":{"symbol":"TLPH","market":"US","secType":"STK","nameCN":"Talphera Inc.","latestPrice":0.4851,"timestamp":1750085992914,"preClose":0.49,"halted":0,"volume":21576,"delay":0,"floatShares":17152700,"shares":20503463,"eps":-0.443843,"marketStatus":"Trading","change":-0.0049,"latestTime":"06-16 11:01:39 EDT","open":0.49,"high":0.49,"low":0.4751,"amount":10465.896211199999,"amplitude":0.030408,"askPrice":0.5,"askSize":100,"bidPrice":0.4801,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.443843,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1750104000000},"marketStatusCode":2,"adr":0,"listingDate":1297400400000,"exchange":"NASDAQ","adjPreClose":0.49,"preHourTrading":{"tag":"盘前","latestPrice":0.49,"preClose":0.49,"latestTime":"08:40 EDT","volume":128,"amount":62.904,"timestamp":1750077606569},"postHourTrading":{"tag":"盘后","latestPrice":0.49,"preClose":0.49,"latestTime":"16:07 EDT","volume":4,"amount":1.9306,"timestamp":1749845252099},"volumeRatio":3.401318,"impliedVol":0.9985,"impliedVolPercentile":0.192},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TLPH\",,,,,undefined,":{"symbol":"TLPH","floatShares":17152700,"roa":"-39.79%","roe":"-106.83%","lyrEps":-0.50314,"volumeRatio":3.401318,"shares":20503463,"dividePrice":0,"high":0.49,"amplitude":0.030408,"preClose":0.49,"low":0.4751,"week52Low":0.45,"pbRate":"1.78","psRate":"368.38","week52High":1.19,"institutionHeld":0,"latestPrice":0.4851,"eps":-0.443843,"divideRate":0,"volume":21576,"delay":0,"ttmEps":-0.443843,"open":0.49,"prevYearClose":0.5241,"prevWeekClose":0.49,"prevMonthClose":0.491,"prevQuarterClose":0.495,"fiveDayClose":0.5151,"twentyDayClose":0.504,"sixtyDayClose":0.616},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TLPH\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2541006741","title":"Talphera Inc. Receives Nasdaq Extension to Regain Compliance with $1.00 Bid Price Rule","url":"https://stock-news.laohu8.com/highlight/detail?id=2541006741","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541006741?lang=en_us&edition=fundamental","pubTime":"2025-06-06 05:03","pubTimestamp":1749157397,"startTime":"0","endTime":"0","summary":"Talphera Inc. Faces Potential Delisting from Nasdaq On June 5, 2025, Talphera Inc. announced it received a written notice from the Nasdaq Stock Market's Listing Qualifications Staff, granting the company an additional 180 days, until December 1, 2025, to comply with the $1.00 minimum bid price requirement per share as per Nasdaq Listing Rule 5550. The company's stock had previously closed below this threshold for 30 consecutive business days, prompting the initial warning. Talphera's stock was transferred to The Nasdaq Capital Market on May 30, 2025, following the company's failure to meet the criteria for The Nasdaq Global Select Market. The company is considering measures, including a potential reverse stock split, to address the deficiency. Failure to comply by the deadline could result in delisting, although Talphera would have the option to appeal the decision.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250605:nNDLKg6pP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLPH","BK4007"],"gpt_icon":0},{"id":"2535379948","title":"Talphera Inc reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2535379948","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535379948?lang=en_us&edition=fundamental","pubTime":"2025-05-15 10:22","pubTimestamp":1747275767,"startTime":"0","endTime":"0","summary":"Talphera Inc reports results for the quarter ended March 31 - Earnings SummaryTalphera Inc TLPH.OQ reported a quarterly adjusted loss of 10 cents per share for the quarter ended March 31, higher than ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250515:nL8N3RN014:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLPH"],"gpt_icon":0},{"id":"2535230007","title":"Talphera Inc. Reports Q1 2025 Net Loss of $2.6 Million, EPS Improves to $0.10 from $0.16 in 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2535230007","media":"Reuters","labels":["dataReport","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535230007?lang=en_us&edition=fundamental","pubTime":"2025-05-15 04:20","pubTimestamp":1747254020,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Talphera Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 14, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250514:nNDL6P9bxD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLPH"],"gpt_icon":0},{"id":"2535200756","title":"Talphera Q1 EPS $(0.10) Beats $(0.14) Estimate, Sales $27.00K","url":"https://stock-news.laohu8.com/highlight/detail?id=2535200756","media":"Benzinga","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535200756?lang=en_us&edition=fundamental","pubTime":"2025-05-15 04:12","pubTimestamp":1747253558,"startTime":"0","endTime":"0","summary":"Talphera (NASDAQ:TLPH) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.14) by 28.57 percent. This is a 37.5 percent increase over losses of $(0.16) per share from the same","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/05/45420293/talphera-q1-eps-0-10-beats-0-14-estimate-sales-27-00k","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLPH"],"gpt_icon":0},{"id":"2535033784","title":"Talphera Inc  expected to post a loss of 15 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2535033784","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535033784?lang=en_us&edition=fundamental","pubTime":"2025-05-13 04:39","pubTimestamp":1747082345,"startTime":"0","endTime":"0","summary":"Talphera Inc  expected to post a loss of15cents a share - Earnings Preview Talphera Inc TLPH.OQ TLPH.O is expected to show no change in quarterly revenue when it reports  results on May 14 for the per","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250512:nL8N3RK2LS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLPH"],"gpt_icon":0},{"id":"2534470487","title":"Talphera Inc  expected to post a loss of 15 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2534470487","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534470487?lang=en_us&edition=fundamental","pubTime":"2025-05-09 21:37","pubTimestamp":1746797827,"startTime":"0","endTime":"0","summary":"Talphera Inc  expected to post a loss of15cents a share - Earnings Preview Talphera Inc TLPH.OQ TLPH.O is expected to show no change in quarterly revenue when it reports  results on May 14 for the per","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250509:nL8N3RH1XT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLPH"],"gpt_icon":0},{"id":"2524011890","title":"Talphera Price Target Maintained With a $6.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2524011890","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524011890?lang=en_us&edition=fundamental","pubTime":"2025-04-01 20:12","pubTimestamp":1743509520,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TLPH/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 01, 2025 08:12 ET (12:12 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLPH"],"gpt_icon":0},{"id":"2524906488","title":"BRIEF-Talphera Expected To Provide Capital Through Target Completion Of Nephro Study In Q4 Of 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2524906488","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524906488?lang=en_us&edition=fundamental","pubTime":"2025-04-01 06:42","pubTimestamp":1743460938,"startTime":"0","endTime":"0","summary":"BRIEF-Talphera Expected To Provide Capital Through Target Completion Of Nephro Study In Q4 Of 2025Talphera Inc TLPH.O:TALPHERA: EXPECTED TO PROVIDE CAPITAL THROUGH TARGET COMPLETION OF NEPHRO STUDY IN Q4 OF 2025Source text: ID:nPn4ynDl9aFurther company coverage: TLPH.O","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250331:nFWN3QE0WZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","TLPH"],"gpt_icon":0},{"id":"2524970177","title":"Talphera Inc reports results for the quarter ended December 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2524970177","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524970177?lang=en_us&edition=fundamental","pubTime":"2025-04-01 05:01","pubTimestamp":1743454886,"startTime":"0","endTime":"0","summary":"Talphera Inc reports results for the quarter ended December 31 - Earnings SummaryTalphera Inc TLPH.OQ reported a quarterly adjusted loss of 7 cents per share for the quarter ended December 31, higher ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250331:nL5N3QE1P5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLPH"],"gpt_icon":0},{"id":"2524397248","title":"Talphera: Expected to Provide Capital Through Target Completion of Nephro Study in Q4 of 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2524397248","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524397248?lang=en_us&edition=fundamental","pubTime":"2025-04-01 04:27","pubTimestamp":1743452821,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250331:nFWN3QE0WZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","TLPH"],"gpt_icon":0},{"id":"2524742899","title":"Talphera Q4 2024 GAAP EPS $(0.07) Beats $(0.16) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2524742899","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524742899?lang=en_us&edition=fundamental","pubTime":"2025-04-01 04:09","pubTimestamp":1743451752,"startTime":"0","endTime":"0","summary":"Talphera (NASDAQ:TLPH) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.16) by 56.25 percent. This is a 72 percent increase over losses of $(0.25) per share from the same","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/03/44570987/talphera-q4-2024-gaap-eps-0-07-beats-0-16-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLPH"],"gpt_icon":0},{"id":"2523926373","title":"Talphera to Reduce Size of Renal Replacement Therapy Study, Enters Private Placement; Shares Fall","url":"https://stock-news.laohu8.com/highlight/detail?id=2523926373","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523926373?lang=en_us&edition=fundamental","pubTime":"2025-03-31 22:59","pubTimestamp":1743433184,"startTime":"0","endTime":"0","summary":"Talphera  said Monday it has entered an agreement with the US Food and Drug Administration to reduce the size of a study evaluating patients undergoing renal replacement therapy to 70 patients from 166 that were previously included in the study protocol.The company also said it entered into agreements with institutional investors and a company executive for a private placement of common stock and pre-funded warrants, potentially raising up to $14.8 million.The private placement includes three closings -- the first will raise $4.925 million on April 2, the second and third closings are contingent on milestones, including enrolling at least 17 and 35 patients in the study, and meeting stock price requirements. In total, Talphera said it plans to issue up to about 3.4 million common shares and nearly 5 million pre-funded warrants at $0.586 per share and $0.585 per warrant.Shares of Talphera were down 13% in recent trading activity.Price: 0.51, Change: -0.08, Percent Change: -12.97","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","TLPH"],"gpt_icon":0},{"id":"2523876949","title":"Talphera Inc - Talphera Believes Nephro Crrt Study Should Be Completed by End of 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2523876949","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523876949?lang=en_us&edition=fundamental","pubTime":"2025-03-31 20:30","pubTimestamp":1743424210,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250331:nFWN3QE1E6:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TLPH","BK4007"],"gpt_icon":0},{"id":"2523498739","title":"Talphera Announces Agreement With the FDA to Reduce the Nephro Crrt Study Size to 70 Patients From 166 and a Private Placement Financing Priced at-the Market of up to $14.8 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2523498739","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523498739?lang=en_us&edition=fundamental","pubTime":"2025-03-31 20:30","pubTimestamp":1743424210,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250331:nFWN3QE1E6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TLPH","BK4007"],"gpt_icon":0},{"id":"2519877814","title":"Talphera Inc  expected to post a loss of 16 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2519877814","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519877814?lang=en_us&edition=fundamental","pubTime":"2025-03-14 19:11","pubTimestamp":1741950665,"startTime":"0","endTime":"0","summary":"Talphera Inc  expected to post a loss of16cents a share - Earnings Preview Talphera Inc TLPH.OQ TLPH.O is expected to show a fall in quarterly revenue when it reports  results on March 17 (estimated) ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250314:nL8N3PX0TC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLPH"],"gpt_icon":0},{"id":"2514334703","title":"Talphera Inc  expected to post a loss of 16 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2514334703","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514334703?lang=en_us&edition=fundamental","pubTime":"2025-02-28 19:22","pubTimestamp":1740741741,"startTime":"0","endTime":"0","summary":"Talphera Inc  expected to post a loss of16cents a share - Earnings Preview Talphera Inc TLPH.OQ TLPH.O is expected to show a fall in quarterly revenue when it reports  results on March 4 (estimated) f","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250228:nL5N3PJ0YI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLPH"],"gpt_icon":0},{"id":"2503095578","title":"Talphera reaches agreement with FDA in Nephro CRRT study","url":"https://stock-news.laohu8.com/highlight/detail?id=2503095578","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503095578?lang=en_us&edition=fundamental","pubTime":"2025-01-14 21:35","pubTimestamp":1736861750,"startTime":"0","endTime":"0","summary":"Talphera (TLPH) announced that following a meeting with the FDA, the agency has agreed to review a Prior Approval Supplement requesting a reduction...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/talphera-reaches-agreement-with-fda-in-nephro-crrt-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/talphera-reaches-agreement-with-fda-in-nephro-crrt-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","TLPH"],"gpt_icon":0},{"id":"2503578441","title":"BRIEF-Talphera Announces Agreement With The FDA For Prior Approval Supplement Review To Reduce The Number Of Patients In The the NEPHRO CRRT Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2503578441","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503578441?lang=en_us&edition=fundamental","pubTime":"2025-01-14 21:31","pubTimestamp":1736861470,"startTime":"0","endTime":"0","summary":"Jan 14  - Talphera Inc   :   * TALPHERA ANNOUNCES AGREEMENT WITH THE FDA FOR PRIOR APPROVAL SUPPLEMENT REVIEW TO REDUCE THE NUMBER OF PATIENTS IN THE NEPHRO CRRT STUDY   * TALPHERA INC: FDA AGREED TO TWO ADDITIONAL PROTOCOL CHANGES EXPECTED TO ACCELERATE ENROLLMENT IN NEPHRO CRRT STUDYSource text:    Further company coverage:    ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"BRIEF-Talphera Announces Agreement With The FDA For Prior Approval Supplement Review To Reduce The Number Of Patients In The the NEPHRO CRRT Study","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLPH","BK4007"],"gpt_icon":0},{"id":"2503781165","title":"Talphera Inc: FDA Agreed to Two Additional Protocol Changes Expected to Accelerate Enrollment in Nephro Crrt Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2503781165","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503781165?lang=en_us&edition=fundamental","pubTime":"2025-01-14 21:30","pubTimestamp":1736861411,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250114:nFWN3OA0D1:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TLPH","BK4007"],"gpt_icon":0},{"id":"2503781455","title":"Talphera Announces Agreement With the FDA for Prior Approval Supplement Review to Reduce the Number of Patients in the Nephro Crrt Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2503781455","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503781455?lang=en_us&edition=fundamental","pubTime":"2025-01-14 21:30","pubTimestamp":1736861406,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250114:nTUAG0L9L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TLPH","BK4007"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":21,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TLPH\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-14","symbol":"TLPH","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747195200000,"reportTimeType":"post","actualEps":-0.1},{"market":"US","date":"2025-03-31","symbol":"TLPH","fiscalQuarterEnding":"2024/12","expectedEps":-0.21,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1743393600000,"reportTimeType":"post","actualEps":-0.07},{"market":"US","date":"2024-11-13","symbol":"TLPH","fiscalQuarterEnding":"2024/09","expectedEps":-0.2,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731474000000,"reportTimeType":"post","actualEps":-0.13},{"market":"US","date":"2024-08-14","symbol":"TLPH","fiscalQuarterEnding":"2024/06","expectedEps":-0.22,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723608000000,"reportTimeType":"post","actualEps":-0.15},{"market":"US","date":"2024-05-14","symbol":"TLPH","fiscalQuarterEnding":"2024/03","expectedEps":-0.28,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715659200000,"reportTimeType":"post","actualEps":-0.16}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TLPH\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TLPH\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":3,"updateTime":1715054400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/TLPH\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"TLPH","date":"2025-06-13","current":-0.895475,"percent":0.510386,"low":-1.454079,"twenty":-1.118448,"median":-0.90459,"eighty":-0.677869,"high":-0.538589,"avg":-0.901667,"sd":0.215938,"marketCap":10426010},"quantilePoints":[{"date":"2024-01-12","current":-0.709783,"twenty":-0.709783,"median":-0.709783,"eighty":-0.709783,"marketCap":15163804},{"date":"2024-01-19","current":-0.768899,"twenty":-0.721606,"median":-0.626863,"eighty":-0.622514,"marketCap":16426748},{"date":"2024-01-26","current":-0.825237,"twenty":-0.834759,"median":-0.716726,"eighty":-0.626609,"marketCap":17630359},{"date":"2024-02-02","current":-0.833172,"twenty":-0.841107,"median":-0.817302,"eighty":-0.683994,"marketCap":17799882},{"date":"2024-02-09","current":-0.682417,"twenty":-0.826824,"median":-0.749854,"eighty":-0.688766,"marketCap":14579166},{"date":"2024-02-16","current":-0.817314,"twenty":-0.826824,"median":-0.768899,"eighty":-0.696692,"marketCap":17461094},{"date":"2024-02-23","current":-1.047431,"twenty":-0.872852,"median":-0.817302,"eighty":-0.705181,"marketCap":22377325},{"date":"2024-03-01","current":-1.079172,"twenty":-0.991886,"median":-0.817314,"eighty":-0.710598,"marketCap":23055425},{"date":"2024-03-08","current":-1.045883,"twenty":-1.042051,"median":-0.825237,"eighty":-0.718658,"marketCap":19241109},{"date":"2024-03-15","current":-1.051518,"twenty":-1.046502,"median":-0.872847,"eighty":-0.724723,"marketCap":19344777},{"date":"2024-03-22","current":-1.03307,"twenty":-1.051518,"median":-0.952196,"eighty":-0.737703,"marketCap":19005395},{"date":"2024-03-28","current":-1.014623,"twenty":-1.051518,"median":-0.991886,"eighty":-0.749061,"marketCap":18666013},{"date":"2024-04-05","current":-1.014623,"twenty":-1.051518,"median":-0.977516,"eighty":-0.759853,"marketCap":18666013},{"date":"2024-04-12","current":-1.051518,"twenty":-1.060742,"median":-0.991886,"eighty":-0.78826,"marketCap":19344777},{"date":"2024-04-19","current":-0.95928,"twenty":-1.057052,"median":-0.989418,"eighty":-0.817302,"marketCap":17647867},{"date":"2024-04-26","current":-1.03307,"twenty":-1.051518,"median":-0.968081,"eighty":-0.817307,"marketCap":19005395},{"date":"2024-05-03","current":-0.942156,"twenty":-1.051518,"median":-0.955738,"eighty":-0.817314,"marketCap":17332836},{"date":"2024-05-10","current":-0.942156,"twenty":-1.051518,"median":-0.951392,"eighty":-0.817314,"marketCap":17332836},{"date":"2024-05-17","current":-1.376289,"twenty":-1.051518,"median":-0.951439,"eighty":-0.820483,"marketCap":19541923},{"date":"2024-05-24","current":-1.244644,"twenty":-1.066276,"median":-0.95928,"eighty":-0.825237,"marketCap":17672696},{"date":"2024-05-31","current":-1.220708,"twenty":-1.07919,"median":-0.968081,"eighty":-0.826824,"marketCap":17332836},{"date":"2024-06-07","current":-1.172597,"twenty":-1.105016,"median":-0.989418,"eighty":-0.838101,"marketCap":16649701},{"date":"2024-06-14","current":-1.172837,"twenty":-1.162665,"median":-0.991886,"eighty":-0.857817,"marketCap":16653117},{"date":"2024-06-21","current":-0.989731,"twenty":-1.167223,"median":-0.991886,"eighty":-0.86955,"marketCap":14053191},{"date":"2024-06-28","current":-1.089063,"twenty":-1.169518,"median":-0.998642,"eighty":-0.872556,"marketCap":15463609},{"date":"2024-07-05","current":-1.101031,"twenty":-1.166458,"median":-1.010011,"eighty":-0.872847,"marketCap":15633538},{"date":"2024-07-12","current":-1.078532,"twenty":-1.162665,"median":-1.014623,"eighty":-0.872847,"marketCap":15314070},{"date":"2024-07-15","current":-1.112999,"twenty":-1.155488,"median":-1.023092,"eighty":-0.872849,"marketCap":15803468},{"date":"2024-08-02","current":-1.11611,"twenty":-1.148312,"median":-1.031561,"eighty":-0.872852,"marketCap":15847650},{"date":"2024-08-09","current":-1.1495,"twenty":-1.140413,"median":-1.03307,"eighty":-0.881601,"marketCap":16321754},{"date":"2024-08-16","current":-1.082672,"twenty":-1.150506,"median":-1.03307,"eighty":-0.89914,"marketCap":14783889},{"date":"2024-08-23","current":-1.12013,"twenty":-1.150506,"median":-1.041541,"eighty":-0.908733,"marketCap":15295378},{"date":"2024-08-30","current":-1.214584,"twenty":-1.160535,"median":-1.047431,"eighty":-0.91316,"marketCap":16585145},{"date":"2024-09-06","current":-1.256895,"twenty":-1.172134,"median":-1.051518,"eighty":-0.91362,"marketCap":17162906},{"date":"2024-09-13","current":-1.120006,"twenty":-1.172789,"median":-1.052339,"eighty":-0.917105,"marketCap":15293679},{"date":"2024-09-20","current":-1.171526,"twenty":-1.172383,"median":-1.060742,"eighty":-0.925267,"marketCap":15997188},{"date":"2024-09-27","current":-1.007507,"twenty":-1.171277,"median":-1.062038,"eighty":-0.931608,"marketCap":13757514},{"date":"2024-10-04","current":-0.983116,"twenty":-1.169518,"median":-1.060742,"eighty":-0.932246,"marketCap":13424451},{"date":"2024-10-11","current":-0.995561,"twenty":-1.165699,"median":-1.055876,"eighty":-0.935347,"marketCap":13594381},{"date":"2024-10-18","current":-1.443563,"twenty":-1.165699,"median":-1.051518,"eighty":-0.938196,"marketCap":19711853},{"date":"2024-10-25","current":-1.193428,"twenty":-1.172383,"median":-1.059667,"eighty":-0.940832,"marketCap":16296264},{"date":"2024-10-31","current":-1.145268,"twenty":-1.175829,"median":-1.062038,"eighty":-0.940832,"marketCap":15638636},{"date":"2024-11-08","current":-1.120006,"twenty":-1.172837,"median":-1.065997,"eighty":-0.942156,"marketCap":15293679},{"date":"2024-11-15","current":-0.718871,"twenty":-1.172597,"median":-1.067654,"eighty":-0.942156,"marketCap":11251050},{"date":"2024-11-22","current":-0.759152,"twenty":-1.171526,"median":-1.065128,"eighty":-0.934799,"marketCap":11881489},{"date":"2024-11-29","current":-0.769204,"twenty":-1.170532,"median":-1.060742,"eighty":-0.922038,"marketCap":12038805},{"date":"2024-12-06","current":-0.744233,"twenty":-1.169884,"median":-1.055876,"eighty":-0.903567,"marketCap":11647985},{"date":"2024-12-13","current":-0.714964,"twenty":-1.167123,"median":-1.051518,"eighty":-0.872774,"marketCap":11189899},{"date":"2024-12-20","current":-0.671877,"twenty":-1.163424,"median":-1.049475,"eighty":-0.831585,"marketCap":10515542},{"date":"2024-12-27","current":-0.54947,"twenty":-1.159469,"median":-1.044734,"eighty":-0.819817,"marketCap":8599755},{"date":"2025-01-03","current":-0.642064,"twenty":-1.157339,"median":-1.038589,"eighty":-0.817307,"marketCap":10048941},{"date":"2025-01-10","current":-0.632054,"twenty":-1.156244,"median":-1.034537,"eighty":-0.816045,"marketCap":9892272},{"date":"2025-01-17","current":-0.674597,"twenty":-1.151726,"median":-1.03307,"eighty":-0.770977,"marketCap":10558115},{"date":"2025-01-24","current":-0.772522,"twenty":-1.151176,"median":-1.031561,"eighty":-0.769204,"marketCap":12090744},{"date":"2025-01-31","current":-0.761424,"twenty":-1.1495,"median":-1.014623,"eighty":-0.766969,"marketCap":11917046},{"date":"2025-02-07","current":-0.750761,"twenty":-1.145268,"median":-1.008005,"eighty":-0.759152,"marketCap":11750160},{"date":"2025-02-14","current":-0.686565,"twenty":-1.145019,"median":-1.005399,"eighty":-0.750761,"marketCap":10745436},{"date":"2025-02-21","current":-0.665892,"twenty":-1.145019,"median":-0.995934,"eighty":-0.743362,"marketCap":10421881},{"date":"2025-02-28","current":-0.62879,"twenty":-1.144322,"median":-0.991886,"eighty":-0.729,"marketCap":9841185},{"date":"2025-03-07","current":-0.555931,"twenty":-1.135885,"median":-0.989659,"eighty":-0.722709,"marketCap":8700874},{"date":"2025-03-14","current":-0.614754,"twenty":-1.13372,"median":-0.983614,"eighty":-0.709274,"marketCap":9621508},{"date":"2025-03-21","current":-0.670245,"twenty":-1.132699,"median":-0.983116,"eighty":-0.695334,"marketCap":10489998},{"date":"2025-03-28","current":-0.674597,"twenty":-1.130559,"median":-0.968503,"eighty":-0.691179,"marketCap":10558115},{"date":"2025-04-04","current":-0.746305,"twenty":-1.128493,"median":-0.963783,"eighty":-0.690853,"marketCap":9704951},{"date":"2025-04-11","current":-0.644804,"twenty":-1.127045,"median":-0.958352,"eighty":-0.685651,"marketCap":8385028},{"date":"2025-04-17","current":-0.606147,"twenty":-1.125692,"median":-0.951485,"eighty":-0.684843,"marketCap":7882337},{"date":"2025-04-25","current":-0.637835,"twenty":-1.122064,"median":-0.950724,"eighty":-0.677643,"marketCap":8294407},{"date":"2025-05-02","current":-0.672679,"twenty":-1.120056,"median":-0.942156,"eighty":-0.674597,"marketCap":8747513},{"date":"2025-05-09","current":-0.724352,"twenty":-1.120006,"median":-0.941494,"eighty":-0.674597,"marketCap":9419478},{"date":"2025-05-16","current":-0.71959,"twenty":-1.120006,"median":-0.937537,"eighty":-0.674597,"marketCap":8378189},{"date":"2025-05-23","current":-0.74015,"twenty":-1.120006,"median":-0.931608,"eighty":-0.674727,"marketCap":8617565},{"date":"2025-05-30","current":-0.719737,"twenty":-1.120006,"median":-0.919571,"eighty":-0.675162,"marketCap":8379898},{"date":"2025-06-06","current":-0.858669,"twenty":-1.120006,"median":-0.91316,"eighty":-0.676271,"marketCap":9997488},{"date":"2025-06-13","current":-0.895475,"twenty":-1.118448,"median":-0.90459,"eighty":-0.677869,"marketCap":10426010}],"updateTime":1750065095379}}}